Current controversies and developments on the role of lymphadenectomy for penile cancer

Urol Oncol. 2019 Mar;37(3):201-208. doi: 10.1016/j.urolonc.2018.08.017. Epub 2018 Oct 6.

Abstract

Penile squamous cell carcinoma is a rare cancer in men. The main prognosticators of survival for penile cancer patients remain the presence and the extent of lymph node metastasis. While radical inguinal lymphadenectomy has been the cornerstone of regional lymph node management for many years, it is still associated with significant morbidity and psychological distress. Recent developments in penile squamous cell carcinoma management have been met with some controversy in the urologic oncology community. Herein, we review the current controversies and developments on the role of inguinal lymphadenectomy for penile cancer.

Keywords: Lymph node metastasis; Lymphadenectomy; Minimally invasive surgery; Penile squamous cell carcinoma; Systemic therapy.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / analysis
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy*
  • Chemoradiotherapy / methods
  • Humans
  • Inguinal Canal
  • Lymph Node Excision / adverse effects
  • Lymph Node Excision / methods*
  • Lymphatic Metastasis / diagnosis*
  • Lymphatic Metastasis / pathology
  • Lymphatic Metastasis / therapy
  • Male
  • Minimally Invasive Surgical Procedures / adverse effects
  • Minimally Invasive Surgical Procedures / methods
  • Neoadjuvant Therapy / methods
  • Neoplasm Staging
  • Penile Neoplasms / diagnosis
  • Penile Neoplasms / pathology
  • Penile Neoplasms / therapy*
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control*
  • Prognosis
  • Salvage Therapy / adverse effects
  • Salvage Therapy / methods
  • Sentinel Lymph Node / diagnostic imaging
  • Sentinel Lymph Node / pathology
  • Sentinel Lymph Node / surgery
  • Sentinel Lymph Node Biopsy

Substances

  • Biomarkers, Tumor